Literature DB >> 22767636

Serum sclerostin increases in healthy adult men during bed rest.

J M Spatz1, E E Fields, E W Yu, P Divieti Pajevic, M L Bouxsein, J D Sibonga, S R Zwart, S M Smith.   

Abstract

CONTEXT: Animal models and human studies suggest that osteocytes regulate the skeleton's response to mechanical unloading in part by an increase in sclerostin. However, few studies have reported changes in serum sclerostin in humans exposed to reduced mechanical loading. <br> OBJECTIVE: We determined changes in serum sclerostin and bone turnover markers in healthy adult men undergoing controlled bed rest. DESIGN, SETTING, AND PARTICIPANTS: Seven healthy adult men (31 ± 3 yr old) underwent 90 d of 6° head down tilt bed rest at the University of Texas Medical Branch Institute for Translational Sciences-Clinical Research Center. OUTCOMES: Serum sclerostin, PTH, vitamin D, bone resorption and formation markers, urinary calcium and phosphorus excretion, and 24-h pooled urinary markers of bone resorption were evaluated before bed rest [baseline (BL)] and at bed rest d 28 (BR-28), d 60 (BR-60), and d 90 (BR-90). Bone mineral density was measured at BL, BR-60, and 5 d after the end of the study (BR+5). Data are reported as mean ± SD. <br> RESULTS: Consistent with prior reports, bone mineral density declined significantly (1-2% per month) at weight-bearing skeletal sites. Serum sclerostin was elevated above BL at BR-28 (+29 ± 20%; P = 0.003) and BR-60 (+42 ± 31%; P < 0.001), with a lesser increase at BR-90 (+22 ± 21%; P = 0.07). Serum PTH levels were reduced at BR-28 (-17 ± 16%; P = 0.02) and BR-60 (-24 ± 14%; P = 0.03) and remained lower than BL at BR-90 (-21 ± 21%; P = 0.14), but did not reach statistical significance. Serum bone turnover markers were unchanged; however, urinary bone resorption markers and calcium were significantly elevated at all time points after bed rest (P < 0.01). <br> CONCLUSIONS: In healthy men subjected to controlled bed rest for 90 d, serum sclerostin increased, with a peak at 60, whereas serum PTH declined, and urinary calcium and bone resorption markers increased.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767636      PMCID: PMC3431567          DOI: 10.1210/jc.2012-1579

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Skeletal effects of long-duration head-down bed rest.

Authors:  Elisabeth R Spector; Scott M Smith; Jean D Sibonga
Journal:  Aviat Space Environ Med       Date:  2009-05

2.  Effects of 21 days of bed rest, with or without artificial gravity, on nutritional status of humans.

Authors:  S R Zwart; G E Crawford; P L Gillman; G Kala; A S Rodgers; A Rogers; A M Inniss; B L Rice; K Ericson; S Coburn; Y Bourbeau; E Hudson; G Mathew; D E Dekerlegand; C F Sams; M A Heer; W H Paloski; S M Smith
Journal:  J Appl Physiol (1985)       Date:  2008-12-12

3.  Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.

Authors:  Chuwen Lin; Xuan Jiang; Zhongquan Dai; Xizhi Guo; Tujun Weng; Jun Wang; Yinghui Li; Guoyin Feng; Xiang Gao; Lin He
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

4.  Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.

Authors:  Agostino Gaudio; Pietra Pennisi; Cornelia Bratengeier; Venerando Torrisi; Brigitte Lindner; Roberto A Mangiafico; Ivana Pulvirenti; Gerhard Hawa; Giovanni Tringali; Carmelo E Fiore
Journal:  J Clin Endocrinol Metab       Date:  2010-03-19       Impact factor: 5.958

5.  Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.

Authors:  Matthew T Drake; Bhuma Srinivasan; Ulrike I Mödder; James M Peterson; Louise K McCready; B Lawrence Riggs; Denise Dwyer; Marina Stolina; Paul Kostenuik; Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

6.  Nutritional status assessment before, during, and after long-duration head-down bed rest.

Authors:  Sara R Zwart; Susan A Mathews Oliver; J Vernell Fesperman; Geeta Kala; Jane Krauhs; Karen Ericson; Scott M Smith
Journal:  Aviat Space Environ Med       Date:  2009-05

7.  Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.

Authors:  Alexander G Robling; Paul J Niziolek; Lee A Baldridge; Keith W Condon; Matthew R Allen; Imranul Alam; Sara M Mantila; Jelica Gluhak-Heinrich; Teresita M Bellido; Stephen E Harris; Charles H Turner
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

8.  Evidence for osteocyte regulation of bone homeostasis through RANKL expression.

Authors:  Tomoki Nakashima; Mikihito Hayashi; Takanobu Fukunaga; Kosaku Kurata; Masatsugu Oh-Hora; Jian Q Feng; Lynda F Bonewald; Tatsuhiko Kodama; Anton Wutz; Erwin F Wagner; Josef M Penninger; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

9.  Matrix-embedded cells control osteoclast formation.

Authors:  Jinhu Xiong; Melda Onal; Robert L Jilka; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

10.  Control of bone mass and remodeling by PTH receptor signaling in osteocytes.

Authors:  Charles A O'Brien; Lilian I Plotkin; Carlo Galli; Joseph J Goellner; Arancha R Gortazar; Matthew R Allen; Alexander G Robling; Mary Bouxsein; Ernestina Schipani; Charles H Turner; Robert L Jilka; Robert S Weinstein; Stavros C Manolagas; Teresita Bellido
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

View more
  41 in total

Review 1.  Osteocyte Mechanobiology.

Authors:  Yuhei Uda; Ehab Azab; Ningyuan Sun; Chao Shi; Paola Divieti Pajevic
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

2.  Comparison of two commercially available ELISAs for circulating sclerostin.

Authors:  A G Costa; S Cremers; E Dworakowski; M Lazaretti-Castro; J P Bilezikian
Journal:  Osteoporos Int       Date:  2014-02-22       Impact factor: 4.507

Review 3.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

Review 4.  Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.

Authors:  Evangelia Kalaitzoglou; Iuliana Popescu; R Clay Bunn; John L Fowlkes; Kathryn M Thrailkill
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 5.  A review of osteocyte function and the emerging importance of sclerostin.

Authors:  Jocelyn T Compton; Francis Y Lee
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

6.  Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.

Authors:  U Heilmeier; D R Carpenter; J M Patsch; R Harnish; G B Joseph; A J Burghardt; T Baum; A V Schwartz; T F Lang; T M Link
Journal:  Osteoporos Int       Date:  2015-01-13       Impact factor: 4.507

7.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

Review 8.  Skeletal changes during and after spaceflight.

Authors:  Laurence Vico; Alan Hargens
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 9.  Hormonal and systemic regulation of sclerostin.

Authors:  Matthew T Drake; Sundeep Khosla
Journal:  Bone       Date:  2016-12-10       Impact factor: 4.398

Review 10.  Clinical utility of serum sclerostin measurements.

Authors:  Bart L Clarke; Matthew T Drake
Journal:  Bonekey Rep       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.